Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

intravenous steroids

Known as: intravenous steroid 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Long‐term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids
The long‐term outcome of patients with acute severe ulcerative colitis (ASUC) responding to intravenous steroids (IVS) has been… Expand
2019
2019
Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
BACKGROUND Up to one-third of patients with acute severe ulcerative colitis (ASUC) will fail intravenous steroid (IVS) treatment… Expand
2015
2015
Hyperbaric oxygen for idiopathic sudden hearing loss: is the routine application helpful?
Abstract Conclusion: We recommend the routine application of hyperbaric oxygen (HBO) in conjunction with intravenous steroid (IVS… Expand
2015
2015
[Intratympanic Steroid Treatment for Severe Idiopathic Sudden Sensorineural Hearing Loss].
Systemic steroid therapy is the only standard drug therapy for severe idiopathic sudden sensorineural hearing loss (ISSHL). We… Expand
2014
2014
[Efficacy of intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous steroid treatment].
This study investigated the efficacy of intratympanic steroid (ITS) therapy as a salvage treatment for idiopathic sudden… Expand
1996
1996
Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
  • Transplantation
  • 1996
    • Corpus ID: 26052320
In a 6-month open label, randomized, multicenter trial, we compared the efficacy and safety of mycophenolate mofetil (MMF) with… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE